Characterization of Baseline Lung Allograft Dysfunction in Single Lung Transplant Recipients

Author:

Gerckens Michael12,Mümmler Carlo12,Richard Alexander1,Strodel Johannes1,Mertsch Pontus1,Milger Katrin1,Veit Tobias1,Gade Nils3,Yildirim Ali Önder24,Schneider Christian5,Kauke Teresa5,Michel Sebastian26,Irlbeck Michael7,Behr Jürgen1,Kneidinger Nikolaus18

Affiliation:

1. Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center (CPC), Member of the German Center of Lung Research (DZL), LMU Munich, Munich, Germany.

2. Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich, Member of the German Center of Lung Research (DZL), LMU Munich, Munich, Germany.

3. Department of Internal Medicine I, University Hospital, LMU Munich, Munich, Germany.

4. Institute of Experimental Pneumology, LMU University Hospital, Ludwig Maximilians University of Munich, LMU Munich, Munich, Germany.

5. Division of Thoracic Surgery, LMU University Hospital, LMU Munich, Munich, Germany.

6. Department of Cardiac Surgery, LMU University Hospital, LMU Munich, Munich, Germany.

7. Department of Anaesthesiology, LMU University Hospital, LMU Munich, Munich, Germany.

8. Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Abstract

Background. Baseline lung allograft dysfunction (BLAD) is characterized by the failure to achieve normal baseline lung function after double lung transplantation (DLTX) and is associated with a high risk of mortality. In single lung transplant (SLTX) recipients, however, cutoff values and associated factors have not been explored. Here, we aimed to define BLAD in SLTX recipients, investigate its impact on allograft survival, and identify potential risk factors for BLAD in SLTX recipients. Methods. We performed a retrospective, single-center analysis of the LTX cohort of LMU Munich between 2010 and 2018. In accordance with DLTX cutoffs, BLAD in SLTX recipients was defined as failure to achieve percentage of forced expiratory volume in 1 s and percentage of forced vital capacity of >60% on 2 consecutive tests >3 wk apart. Survival analysis and regression analysis for potential predictors of BLAD were performed. Results. In a cohort of 141 SLTX recipients, 43% of patients met BLAD criteria. SLTX recipients with BLAD demonstrated impaired survival. Native lung hyperinflation was associated with BLAD in obstructive disease, whereas donor/recipient lung size mismatch was associated with BLAD in both obstructive and restrictive underlying diseases. Pulmonary function testing at 3 mo after lung transplantation predicted normal baseline lung function in SLTX recipients with obstructive lung disease. Conclusions. BLAD in SLTX recipients is as relevant as in DLTX recipients and should generally be considered in the follow-up of LTX recipients. Risk factors for BLAD differed between underlying obstructive and restrictive lung disease. A better understanding of associated factors may help in the development of preventive strategies.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference23 articles.

1. Lung transplantation for COPD/pulmonary emphysema.;Verleden;Eur Respir Rev,2023

2. Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis.;Neurohr;Transpl Int,2010

3. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data.;Thabut;Lancet,2008

4. Single versus bilateral lung transplantation: do guidelines exist?;Puri;Thorac Surg Clin,2015

5. Effect of changes in postoperative spirometry on survival after lung transplantation.;Mason;J Thorac Cardiovasc Surg,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3